EvokAI Creative Labs (TSXV:OKAI) YoY EBITDA Growth: 10.26% (As of Sep. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSXV:OKAI EvokAI Creative Labs Inc TSXV:OKAI
15 GF Score
Price C$0.12
View Full Analysis

What is EvokAI Creative Labs YoY EBITDA Growth?

EvokAI Creative Labs TSXV:OKAI 15 YoY EBITDA Growth is 10.26% as of Sep. 2024. GuruFocus rates TSXV:OKAI with a GF Score™ of 15/100.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. EvokAI Creative Labs's YoY EBITDA Growth for the quarter that ended in Sep. 2024 was 10.26%.

EvokAI Creative Labs's EBITDA per Share for the three months ended in Sep. 2024 was C$-0.04.

EvokAI Creative Labs YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for EvokAI Creative Labs's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

EvokAI Creative Labs YoY EBITDA Growth Chart

EvokAI Creative Labs Annual Data
Trend Dec21 Dec22 Dec23
YoY EBITDA Growth
0.00 0.00 -2,842.61

EvokAI Creative Labs Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 67.23 -3,343.08 1.30 93.16 10.26
TSXV:OKAI
15GF Score
EvokAI Creative Labs Inc TSXV:OKAI
YoY EBITDA Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

EvokAI Creative Labs YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

EvokAI Creative Labs's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (A: Dec. 2023 )
=(EBITDA per Share (A: Dec. 2023 )-EBITDA per Share (A: Dec. 2022 ))/ | EBITDA per Share (A: Dec. 2022 ) |
=(-3.384--0.115)/ | -0.115 |
=-2,842.61 %

EvokAI Creative Labs's YoY EBITDA Growth for the quarter that ended in Sep. 2024 is calculated as:

YoY EBITDA Growth (Q: Sep. 2024 )
=(EBITDA per Share (Q: Sep. 2024 )-EBITDA per Share (Q: Sep. 2023 )) / | EBITDA per Share (Q: Sep. 2023 )) |
=(-0.035--0.039)/ | -0.039 |
=10.26 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of 10.26% mean?
EvokAI Creative Labs (TSXV:OKAI) has a YoY EBITDA Growth of 10.26% as of Sep. 2024. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for EvokAI Creative Labs and its competitors.
Is EvokAI Creative Labs' YoY EBITDA Growth too high?
EvokAI Creative Labs' current YoY EBITDA Growth is 10.26%. Overall, EvokAI Creative Labs has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does EvokAI Creative Labs' YoY EBITDA Growth compare to VEEV and GEHC?
EvokAI Creative Labs' YoY EBITDA Growth of 10.26% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Healthcare Providers & Services company?
A good YoY EBITDA Growth depends on the Healthcare Providers & Services industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for EvokAI Creative Labs and its competitors. EvokAI Creative Labs's current YoY EBITDA Growth is 10.26%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EvokAI Creative Labs stock overvalued right now?
EvokAI Creative Labs (TSXV:OKAI) has a current YoY EBITDA Growth of 10.26%. The current YoY EBITDA Growth is 10.26%. EvokAI Creative Labs' overall GF Score™ is 15/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For EvokAI Creative Labs (TSXV:OKAI), the current YoY EBITDA Growth is 10.26% as of Sep. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

EvokAI Creative Labs Business Description

Address 609 Granville Street, Suite 1600, PO Box 10068, Pacific Centre, Vancouver, BC, CAN, V7Y 1C3
EvokAI Creative Labs Inc is a medtech artificial-intelligence-powered company. It deploys machine learning models to search medical data and uncover insights to help improve health outcomes, patient experiences, drug development, preclinical and clinical decisions, and provide more accurate diagnoses. EvokAI tailors its AI algorithms across the whole healthcare system, from hospitals, private clinics, research institutions, pharmaceutical companies, and contract research organizations to medical professionals, patients, and healthy individuals aiming at preventing and early detecting any kind of disease and beyond, protecting the aging genome.
15GF Score

Get the complete analysis for TSXV:OKAI

YoY EBITDA Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$0.12
Price